Emerging topics and new perspectives on HLA-G

Cellular and Molecular Life Sciences

Volumn 68, Issue 3, 2011, Pages 433-451

  Fainardi, Enrico ^a   Castellazzi, Massimiliano ^b   Stignani, Marina ^b   Morandi, Fabio ^c   Sana, Gwenaëlle ^d   Gonzalez, Rafael ^e   Pistoia, Vito ^c   Baricordi, Olavio Roberto ^b   Sokal, Etienne ^d   Peña, Josè ^e  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Cytokine chemokine network; HLA G; Inflammation; Stem cells; Viral infection

Indexed keywords

BETA INTERFERON; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; ERYTHROPOIETIN; HLA G ANTIGEN; IMMUNOGLOBULIN RECEPTOR; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; JANUS KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; STAT PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN FUNCTION; ANTIGEN STRUCTURE; ASTHMA; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN INJURY; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVATION; GASTROINTESTINAL DISEASE; GENETIC TRANSCRIPTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION RISK; MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; RHEUMATIC DISEASE; SKIN DISEASE; STEM CELL TRANSPLANTATION; UPREGULATION; VIRUS INFECTION; VIRUS TRANSMISSION;

ANIMALS; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOLOGIC SURVEILLANCE; IMMUNOMODULATION; INFLAMMATION; STEM CELL TRANSPLANTATION; VIRUS DISEASES; VIRUSES;

HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA A VIRUS; RABIES VIRUS;

EID: 79951554730     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0584-3     Document Type: Review

References (148)

1. ED Carosella P Moreau J LeMaoult N Rouas-Freiss 2008 HLA-G: from biology to clinical benefits Trends Immunol 3 125 132
2. ED Carosella B Favier N Rouas-Freiss P Moreau J LeMaoult 2008 Beyond the increasing complexity of the immunomodulatory HLA-G molecules Blood 111 4862 4870 1:CAS:528:DC%2BD1cXmtlaitbg%3D 18334671
3. A Ishitani DE Gerarthy 1992 Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens Proc Natl Acad Sci USA 89 3947 3951 1:CAS:528:DyaK38XktVGlu78%3D 1570318
4. P Paul FA Cabestre EC Ibrahim S Lefevbre I Khalil-Daher G Vazeux RM Quiles F Bermond J Dausset ED Carosella 2000 Identification of HLA-G7 as a new slice variant of the HLA-G mRNA and expression of soluble HL-G5, -G6, and -G7 transcripts in human transfected cells Hum Immunol 61 1138 1149 1:CAS:528:DC%2BD3MXntlWjug%3D%3D 11137219 (Pubitemid 32043892)
5. S Kovats EK Main C Librach M Stubblebine SJ Fisher R DeMars 1990 A class I antigen, HL-G, expressed in human trophoblasts Science 144 220 223 (Pubitemid 120031455)
6. J LeMaoult M Le Discorde N Rouas-Freiss P Moreau C Menier J McCluskey ED Carosella 2003 Biology and functions of human leukocyte antigen-G in health and sickness Tissue Antigens 62 273 284 1:CAS:528:DC%2BD3sXos12nurk%3D 12974794 (Pubitemid 37204582)
7. SA Ellis LS Palmer AJ McMichael 1990 Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule J Immunol 144 731 735 1:CAS:528:DyaK3cXktFylu7g%3D 2295808 (Pubitemid 20036109)
8. V Mallet A Blaschitz L Crisa C Schmitt S Fournel A King YW Loke G Dohr P Le Bouteiller 1999 HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein Int Immunol 11 889 898 1:CAS:528:DyaK1MXkt1CjtbY%3D 10360962 (Pubitemid 29276600)
9. M Le Discorde P Moreau P Sabatier JM Legeais ED Carosella 2003 Expression of HLA-G in human cornea, an immune-privileged tissue Hum Immunol 64 1039 1044 1:CAS:528:DC%2BD3sXos1Kgu70%3D 14602233 (Pubitemid 37413712)
10. T Ito N Ito M Saathoff B Stampachiacchiere A Bettermann S Bulfone-Paus M Takigawa BJ Nickoloff R Paus 2005 Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege J Invest Dermatol 125 1139 1148 1:CAS:528:DC%2BD28XjvFKrtw%3D%3D 16354183
11. V Cirulli J Zalatan M McMaster R Prinsen DR Salomon C Ricordi BE Torbett P Meda L Crisa 2006 The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G Diabetes 55 1214 1222 1:CAS:528:DC%2BD28XksFahtrk%3D 16644675 (Pubitemid 44195357)
12. C Menier M Rabreau JC Challier M Le Discorde ED Carosella N Rouas-Freiss 2004 Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis Blood 104 3153 3160 1:CAS:528:DC%2BD2cXhtVWhurzF 15284117 (Pubitemid 39507129)
13. P Moreau F Adrian-Cabestre C Menier V Guiard L Gourand J Dausset ED Carosella P Paul 1999 IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes Int Immunol 11 803 811 1:CAS:528:DyaK1MXjs1Oltb8%3D 10330285 (Pubitemid 29237771)
14. R Rizzo L Melchiorri M Stignani OR Baricordi 2007 HLA-G expression is a fundamental prerequisite to pregnancy Hum Immunol 68 244 250 1:CAS:528:DC%2BD2sXjslShsr8%3D 17400059 (Pubitemid 46497515)
15. N Lila C Amrein R Guillemain P Chevalier C Latremouille JN Fabiani J Dausset ED Carosella A Carpentier 2002 Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection Circulation 105 1949 1954 11997282 (Pubitemid 34437623)
16. V Pistoia F Morandi X Wang S Ferrone 2007 Soluble HLA-G: are they clinically relevant? Semin Cancer Biol 17 469 479 1:CAS:528:DC%2BD2sXht12hsrzK 17825579 (Pubitemid 350064562)
17. P Paul N Rouas-Freiss I Khalil-Daher P Moreau B Riteau FA Le Gal MF Avril J Dausset JG Guillet ED Carosella 1998 HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance Proc Natl Acad Sci USA 95 4510 4515 1:CAS:528:DyaK1cXis1Ogs7w%3D 9539768 (Pubitemid 28207943)
18. M Onno C Pangault G Le Friec V Guilloux P Andre R Fauchet 2000 Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection J Immunol 164 6426 6434 1:CAS:528:DC%2BD3cXktFWltLo%3D 10843698 (Pubitemid 30408825)
19. 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94 5249 5254 1:CAS:528: DyaK2sXjtlensrY%3D 9144223 (Pubitemid 27214769)
20. + cells by interacting CD8 J Immunol 164 6100 6104 1:CAS:528:DC%2BD3cXktFWlsLo%3D 10843658 (Pubitemid 30408785)
21. + cells and inhibit cytotoxic T cell activity through CD8 ligation Eur J Immunol 33 125 134 1:CAS:528:DC%2BD3sXos1SmtQ%3D%3D 12594841 (Pubitemid 36157650)
22. + T cell regulatory mechanism Proc Natl Acad Sci USA 98 12150 12155 1:STN:280:DC%2BD3MrlvFajug%3D%3D 11572934 (Pubitemid 32959842)
23. S Le Rond C Azèma I Krawice-Radanne A Durrbach C Guettier ED Carosella N Rouas-Freiss 2006 Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells J Immunol 176 3266 3276 1:CAS:528:DC%2BD28Xhs1eqsrc%3D 16493088
24. A Horuzsko F Lenfant DH Munn AL Mellor 2001 Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice Int Immunol 13 385 394 1:CAS:528:DC%2BD3MXhvVOht70%3D 11222508 (Pubitemid 32179087)
25. M Colonna F Navarro T Bellón M Llano P García J Samaridis L Angman M Cella M López-Botet 1997 A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells J Exp Med 186 1809 1818 1:CAS:528:DyaK2sXnslGisbo%3D 9382880 (Pubitemid 27524591)
26. K Kapasi SE Albert S Yie N Zavazava CL Librach 2000 HLA-G has a concentration-dependent effect on the generation of an allo-CTL response Immunology 101 191 200 1:CAS:528:DC%2BD3cXns1aqt7g%3D 11012772
27. T Kanai T Fujii S Kozuma T Yamashita A Miki A Kikuchi Y Taketani 2001 Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture Mol Hum Reprod 7 195 200 1:CAS:528: DC%2BD3MXhsFahtro%3D 11160846 (Pubitemid 32148347)
28. J LeMaoult J Caumartin M Daouya B Favier S Le Rond A Gonzalez ED Carosella 2007 Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells Blood 109 2040 2048 1:CAS:528:DC%2BD2sXjtFequr4%3D 17077329 (Pubitemid 46348204)
29. J LeMaoult K Zafaranloo C Le Danff ED Carosella 2005 HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells FASEB J 19 662 664 1:CAS:528:DC%2BD2MXjtFaksb4%3D 15670976 (Pubitemid 40471278)
30. ED Carosella P Moreau S Aractingi N Rouas-Freiss 2001 HLA-G: a shield against inflammatory aggression Trends Immunol 22 553 555 1:CAS:528: DC%2BD3MXntV2nu70%3D 11574278 (Pubitemid 33016401)
31. M Sospedra R Martin 2005 Immunology of multiple sclerosis Annu Rev Immunol 23 683 747 1:CAS:528:DC%2BD2MXktFOju7w%3D 15771584 (Pubitemid 40563183)
32. A Compston A Coles 2008 Multiple sclerosis Lancet 372 1502 1517 1:CAS:528:DC%2BD1cXht12gtLvN 18970977
33. WI McDonald A Compston G Edan D Goodkin HP Hartung FD Lublin HF McFarland DW Paty CH Polman SC Reingold M Sandberg-Wollheim W Sibley A Thompson S van den Noort BY Weinshenker JS Wolinsky 2001 Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Ann Neurol 50 121 127 1:STN:280:DC%2BD38%2FitFOhug%3D%3D 11456302
34. E Fainardi R Rizzo L Melchiorri L Vaghi M Castellazzi A Marzola V Govoni E Paolino MR Tola E Granieri OR Baricordi 2003 Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings J Neuroimmunol 142 149 158 1:CAS:528:DC%2BD3sXnsVags7g%3D 14512174 (Pubitemid 38368598)
35. E Fainardi R Rizzo L Melchiorri M Castellazzi E Paolino MR Tola E Granieri OR Baricordi 2006 Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis Mult Scler 12 2 12 1:CAS:528:DC%2BD28Xhs1Klsr0%3D 16459714 (Pubitemid 43169232)
36. E Fainardi R Rizzo L Melchiorri M Stignani M Castellazzi ML Caniatti E Baldi MR Tola E Granieri OR Baricordi 2007 Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis J Neuroimmunol 192 219 225 1:CAS:528:DC%2BD2sXhsVSmu7fK 17997167 (Pubitemid 350218173)
37. E Fainardi R Rizzo L Melchiorri M Stignani M Castellazzi C Tamborino E Paolino MR Tola E Granieri OR Baricordi 2008 CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing remitting multiple sclerosis Mult Scler 14 446 454 1:CAS:528:DC%2BD1cXosFGgsL8%3D 18208868 (Pubitemid 351943856)
38. E Fainardi R Rizzo L Melchiorri M Castellazzi V Govoni L Caniatti E Paolino MR Tola E Granieri OR Baricordi 2004 Beneficial effect of interferon-β 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy J Neuroimmunol 148 206 211 1:CAS:528:DC%2BD2cXht1yktrw%3D 14975603 (Pubitemid 38232657)
39. M Mitsdoerffer B Schreiner B Kieseier O Neuhaus J Dichgans H-P Hartung M Weller H Wiendl 2005 Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-β in vitro and in vivo: rationale for the therapy of multiple sclerosis J Neuroimmunol 159 155 164 1:CAS:528:DC%2BD2MXisl2qsA%3D%3D 15652415 (Pubitemid 40126188)
40. H Wiendl U Feger M Mittelbronn C Jack B Schreiner C Stadelmann J Antel W Brueck R Meyermann A Bar-Or BC Kieseier M Weller 2005 Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity Brain 128 2689 2704 16123145 (Pubitemid 41552952)
41. U Feger E Tolosa YH Huang A Waschbisch T Biedermann A Melms H Wiendl 2007 HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation Blood 110 568 577 1:CAS:528:DC%2BD2sXot1emtrw%3D 17371944 (Pubitemid 47105395)
42. + T cells is IL-10 dependent and reversible J Leukoc Biol 86 273 281 1:CAS:528:DC%2BD1MXps1emu70%3D 19401389
43. YH Huang AL Zozulya C Weidenfeller I Metz D Buck KV Toyka W Brück H Wiendl 2009 Specific central nervous system recruitment of HLA-G (+) regulatory T cells in multiple sclerosis Ann Neurol 66 171 183 1:CAS:528:DC%2BD1MXht1ansrbL 19705413
44. E Fainardi R Rizzo M Castellazzi M Stignani E Granieri OR Baricordi 2009 Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis Hum Immunol 70 981 987 1:CAS:528:DC%2BD1MXhsVajurnP 19651179
45. SA Mayer F Rincon 2005 Treatment of intracerebral haemorrhage Lancet Neurol 4 662 672 16168935 (Pubitemid 41317301)
46. G Xi RF Keep JT Hoff 2006 Mechanisms of brain injury after intracerebral haemorrhage Lancet Neurol 5 53 63 16361023 (Pubitemid 41790696)
47. J Wang S Doré 2007 Inflammation after intracerebral hemorrhage J Cereb Blood Flow Metab 27 894 908 1:CAS:528:DC%2BD2sXlvVSktr0%3D 17033693 (Pubitemid 46659028)
48. E Fainardi R Rizzo A Lupato V Ramponi G De Santis F Garofano M Stignani C Tamborino M Castellazzi I Casetta OR Baricordi 2010 Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage Acta Neurochir 106 Suppl 141 145
49. P Delgado E Cuadrado A Rosell J Alvarez-Sabín A Ortega-Aznar M Hernández-Guillamón A Penalba CA Molina J Montaner 2008 Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage Stroke 39 1730 1734 1:CAS:528:DC%2BD1cXlvFaisbo%3D 18403741
50. Z Wen C Fiocchi 2004 Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis? Clin Dev Immunol 11 195 204 15559364 (Pubitemid 39423298)
51. MI Torres M Le Discorde P Lorite A Ríos MA Gassull A Gil J Maldonado J Dausset ED Carosella 2004 Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease Int Immunol 16 579 583 1:CAS:528:DC%2BD2cXisF2murw%3D 15039388 (Pubitemid 38489432)
52. R Rizzo L Melchiorri L Simone M Stignani A Marzola S Gullini OR Baricordi 2008 Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool? Inflamm Bowel Dis 14 100 105 17886287 (Pubitemid 351196874)
53. TV Hviid S Hylenius C Rorbye LG Nielsen 2003 HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels Immunogenetics 55 63 79 1:CAS:528:DC%2BD3sXjvFequr4%3D 12712263 (Pubitemid 36702743)
54. J Glas HP Török L Tonenchi M Wetzke V Beynon MY Teshome S Cotofana U Schiemann T Griga W Klein JT Epplen C Folwaczny M Folwaczny T Mussack EH Weiss 2007 The 14 bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease Int Immunol 19 621 626 1:CAS:528:DC%2BD2sXmsFShs70%3D 17446213 (Pubitemid 47072205)
55. MI Torres MA López-Casado J Luque J Peña A Ríos 2006 New advances in coeliac disease: serum and intestinal expression of HLA-G Int Immunol 18 713 718 1:CAS:528:DC%2BD28XktlSis7c%3D 16569678 (Pubitemid 43779061)
56. M Urosevic 2007 HLA-G in the skin-friend or foe? Semin Cancer Biol 17 480 484 1:CAS:528:DC%2BD2sXht12hsrzL 17981049 (Pubitemid 350052593)
57. S Aractingi N Briand C Le Danff M Viguier H Bachelez L Michel L Dubertret ED Carosella 2001 HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 159 71 77 1:CAS:528:DC%2BD3MXlslamtbk%3D 11438456 (Pubitemid 33704194)
58. A Borghi E Fogli M Stignani L Melchiorri E Altieri O Baricordi R Rizzo A Virgili 2008 Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease Arch Dermatol Res 300 551 559 1:CAS:528:DC%2BD1cXht12jtL3P 18797896
59. K Khosrotehrani C Le Danff B Reynaud-Mendel L Dubertret ED Carosella S Aractingi 2001 HLA-G expression in atopic dermatitis J Invest Dermatol 117 750 752 1:CAS:528:DC%2BD3MXntFWhtrg%3D 11564188
60. F Yari A Zavaran Hosseini M Nemat Gorgani MR Khorramizadeh P Mansouri A Kazemnejad 2008 Expression of HLA-G in the skin of patients with pemphigus vulgaris Iran J Allergy Asthma Immunol 7 7 12 1:CAS:528:DC%2BD1cXpt1Oqtbo%3D 18322306 (Pubitemid 351534727)
61. E Gazit Y Slomov I Goldberg S Brenner R Loewenthal 2004 HLA-G is associated with pemphigus vulgaris in Jewish patients Hum Immunol 65 39 46 1:CAS:528:DC%2BD3sXhtVWju7bM 14700594 (Pubitemid 38209933)
62. LA Verbruggen V Rebmann C Demanet S De Cock H Grosse-Wilde 2006 Soluble HLA-G in rheumatoid arthritis Hum Immunol 67 561 567 1:CAS:528: DC%2BD28XotlWis7c%3D 16916651 (Pubitemid 44205319)
63. M Feuchtenberger S Müller P Roll A Waschbisch A Schäfer C Kneitz H Wiendl HP Tony 2008 Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis Open Rheumatol J 2 81 88 1:CAS:528:DC%2BD1MXlvVWksg%3D%3D 19156222
64. R Rizzo M Rubini M Govoni M Padovan L Melchiorri M Stignani S Carturan S Ferretti F Trotta OR Baricordi 2006 HLA-G 14 bp polymorphism regulates the methotrexate response in rheumatoid arthritis Pharmacogenet Genomics 16 615 623 1:CAS:528:DC%2BD28XotVWks70%3D 16906016 (Pubitemid 44223073)
65. TD Veit P Vianna I Scheibel CV Brenol JC Brenol RM Xavier A Delgado-Cañedo JE Gutierrez AP Brandalize L Schuler-Faccini JA Chies 2008 Association of the HLA-G 14 bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis Tissue Antigens 71 440 446 1:CAS:528:DC%2BD1cXmt1CksrY%3D 18331529 Erratum in: Tissue Antigens 72, 185 (Pubitemid 351537544)
66. S Rosado G Perez-Chacon S Mellor-Pita I Sanchez-Vegazo C Bellas-Menendez MJ Citores I Losada-Fernandez T Martin-Donaire N Rebolleda P Perez-Aciego 2008 Expression of human leukocyte antigen-G in systemic lupus erythematosus Hum Immunol 69 9 15 1:CAS:528:DC%2BD1cXitlelu74%3D 18295670
67. R Rizzo TV Hviid M Govoni M Padovan M Rubini L Melchiorri M Stignani S Carturan MT Grappa M Fotinidi S Ferretti A Voss H Laustrup P Junker F Trotta OR Baricordi 2008 HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus Tissue Antigens 71 520 529 1:CAS:528:DC%2BD1cXotVajtbk%3D 18380776 (Pubitemid 351697240)
68. TD Veit EA Cordero T Mucenic OA Monticielo JC Brenol RM Xavier A Delgado-Cañedo JA Chies 2009 Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus Lupus 18 424 430 1:CAS:528: DC%2BD1MXlvFKqu7s%3D 19318395
69. FX Wu LJ Wu XY Luo Z Tang MH Yang CM Xie NT Liu JG Zhou JL Guan GH Yuan 2009 Lack of association between HLA-G 14 bp polymorphism and systemic lupus erythematosus in a Han Chinese population Lupus 18 1259 1266 1:CAS:528:DC%2BC3cXoslKmtA%3D%3D 19884219
70. R Rizzo CE Mapp L Melchiorri P Maestrelli A Visentin S Ferretti I Bononi D Miotto OR Baricordi 2005 Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma J Allergy Clin Immunol 115 508 513 1:CAS:528:DC%2BD2MXhvFyhsLw%3D 15753897 (Pubitemid 40341703)
71. F Tahan T Patiroglu 2006 Plasma soluble human leukocyte antigen G levels in asthmatic children Int Arch Allergy Immunol 141 213 216 1:CAS:528: DC%2BD28XhtV2hu7zN 16926540 (Pubitemid 44597740)
72. D Nicolae NJ Cox LA Lester D Schneider Z Tan C Billstrand S Kuldanek J Donfack P Kogut NM Patel J Goodenbour T Howard R Wolf GH Koppelman SR White R Parry DS Postma D Meyers ER Bleecker JS Hunt J Solway C Ober 2005 Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21 Am J Hum Genet 76 349 357 1:CAS:528:DC%2BD2MXpsFeiug%3D%3D 15611928 (Pubitemid 40129561)
73. Z Tan G Randall J Fan B Camoretti-Mercado R Brockman-Schneider L Pan J Solway JE Gern RF Lemanske D Nicolae C Ober 2007 Allele-specific targeting of microRNAs to HLA-G and risk of asthma Am J Hum Genet 81 829 834 1:CAS:528:DC%2BD2sXhtFSktrjI 17847008 (Pubitemid 47596550)
74. CE Mapp S Ferrazzoni R Rizzo D Miotto M Stignani P Boschetto P Maestrelli OR Baricordi 2009 Soluble human leucocyte antigen-G and interleukin-10 levels in isocyanate-induced asthma Clin Exp Allergy 39 812 819 1:CAS:528: DC%2BD1MXnsF2jsLg%3D 19302248
75. S Liang V Ristich H Arase J Dausset ED Carosella A Horuzsko 2008 Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway Proc Natl Acad Sci USA 105 8357 8362 1:CAS:528:DC%2BD1cXnvVKku70%3D 18550825 (Pubitemid 351904760)
76. SJ Park T Nakagawa H Kitamura T Atsumi H Kamon S Sawa D Kamimura N Ueda Y Iwakura K Ishihara M Murakami T Hirano 2004 IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation J Immunol 173 3844 3854 1:CAS:528:DC%2BD2cXnsVWksrc%3D 15356132 (Pubitemid 39280747)
77. C Li BL Houser ML Nicotra JL Strominger 2009 HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells Proc Natl Acad Sci USA 106 5767 5772 1:CAS:528: DC%2BD1MXkvFGgsr4%3D 19304799
78. S Rajagopalan YT Bryceson SP Kuppusamy DE Geraghty A van der Meer I Joosten EO Long 2006 Activation of NK cells by an endocytosed receptor for soluble HLA-G PLoS Biol 4 e9 16366734
79. A van der Meer HG Lukassen B van Cranenbroek EH Weiss DD Braat MJ van Lierop I Joosten 2007 Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells Mol Hum Reprod 13 123 133 17121749 (Pubitemid 46152599)
80. E Morel T Bellon 2008 HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j J Immunol 181 2368 2381 1:CAS:528:DC%2BD1cXptlKqtbg%3D 18684926
81. RH McIntire PJ Morales MG Petroff M Colonna JS Hunt 2004 Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1 J Leukoc Biol 76 1220 1228 1:CAS:528:DC%2BD2cXhtFSit7nP 15459235 (Pubitemid 39602959)
82. I Roth DB Corry RM Locksley JS Abrams MJ Litton SJ Fisher 1996 Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10 J Exp Med 184 539 548 1:CAS:528:DyaK28XltVCrs7k%3D 8760807 (Pubitemid 26324107)
83. M Urosevic R Dummer 2003 HLA-G and IL-10 expression in human cancer-different stories with the same message Semin Cancer Biol 13 337 342 1:CAS:528:DC%2BD3sXptVCntrg%3D 14708713 (Pubitemid 38160932)
84. low are induced by HLA-G: novel human peripheral blood suppressor T cell subsets involved in transplant acceptance Blood 110 3936 4398 1:CAS:528:DC%2BD2sXhtl2qsb7K 17804694
85. G Ciprandi P Contini G Murdaca M DeAmici AM Gallina F Puppo 2009 Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens Int Immunopharmacol 9 1058 1062 1:CAS:528: DC%2BD1MXotFyquro%3D 19410660
86. G Ciprandi P Contini D Fenoglio MP Sormani S Negrini F Puppo F Indiveri 2008 Relationship between soluble HLA-G and HLA-A, -B, -C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis Hum Immunol 69 409 413 1:CAS:528:DC%2BD1cXoslWmtb0%3D 18573288
87. MF Pittenger AM Mackay SC Beck RK Jaiswal R Douglas JD Mosca MA Moorman DW Simonetti S Craig DR Marshak 1999 Multilineage potential of adult human mesenchymal stem cells Science 284 143 147 1:CAS:528:DyaK1MXitlCnu7o%3D 10102814 (Pubitemid 29282067)
88. A Uccelli L Moretta V Pistoia 2006 Immunoregulatory function of mesenchymal stem cells Eur J Immunol 36 2566 2573 1:CAS:528:DC%2BD28XhtFGqtrbI 17013987 (Pubitemid 44608440)
89. A Uccelli L Moretta V Pistoia 2008 Mesenchymal stem cells in health and disease Nat Rev Immunol 8 726 736 1:CAS:528:DC%2BD1cXhtVamu7vF 19172693
90. A Uccelli V Pistoia L Moretta 2007 Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 28 219 226 1:CAS:528:DC%2BD2sXkslKqsr0%3D 17400510 (Pubitemid 46667240)
91. S Aggarwal MF Pittenger 2005 Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 1815 1822 1:CAS:528: DC%2BD2MXhsVGjt7Y%3D 15494428 (Pubitemid 40223708)
92. A Corcione F Benvenuto E Ferretti D Giunti V Cappiello F Cazzanti M Risso F Gualandi GL Mancardi V Pistoia A Uccelli 2006 Human mesenchymal stem cells modulate B cell functions Blood 107 367 372 1:CAS:528:DC%2BD28XhsVGksQ%3D%3D 16141348 (Pubitemid 43053565)
93. XX Jiang Y Zhang B Liu SX Zhang Y Wu XD Yu N Mao 2005 Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells Blood 105 4120 4126 1:CAS:528:DC%2BD2MXktlSrt7k%3D 15692068 (Pubitemid 40656164)
94. GM Spaggiari A Capobianco S Becchetti MC Mingari L Moretta 2006 Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK cell proliferation Blood 107 1484 1490 1:CAS:528:DC%2BD28XhsFemtrg%3D 16239427 (Pubitemid 43242385)
95. F Morandi L Raffaghello G Bianchi F Meloni A Salis E Millo S Ferrone V Barnaba V Pistoia 2008 Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T cell responses against viral or tumor-associated antigens Stem Cells 26 1275 1287 1:CAS:528:DC%2BD1cXnsFCgtLs%3D 18292209
96. + regulatory T cells Stem Cells 26 212 222 1:CAS:528: DC%2BD1cXhvVCktb0%3D 17932417
97. R Rizzo D Campioni M Stignani L Melchiorri GP Bagnara L Bonsi F Alviano G Lanzoni S Moretti A Cuneo F Lanza OR Baricordi 2008 A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells Cytotherapy 10 364 375 1:CAS:528:DC%2BD1cXns1Smu78%3D 18574769 (Pubitemid 351983160)
98. A Nasef A Chapel C Mazurier S Bouchet M Lopez N Mathieu L Sensebe Y Zhang NC Gorin D Thierry L Fouillard 2007 Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells Gene Expr 13 217 226 17605296 (Pubitemid 47024153)
99. A Dorling N Monk R Lechler 2000 HLA-G inhibits the transendothelial cell migration of human NK cells: a strategy for inhibiting xenograft rejection Transplant Proc 32 938 1:CAS:528:DC%2BD3cXlsFCntro%3D 10936283 (Pubitemid 30601812)
100. J McCormick GS Whitley P Le Bouteiller JE Cartwright 2009 Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4 Hum Reprod 24 1339 1345 1:CAS:528:DC%2BD1MXmtlKqu74%3D 19223288
101. A Alcami UH Koszinowski 2000 Viral mechanisms of immune evasion Trends Microbiol 8 410 418 1:STN:280:DC%2BD3cvptlektg%3D%3D 10989308
102. ED Carosella KY HoWangYin B Favier J LeMaoult 2008 HLA-G-dependent suppressor cells: diverse by nature, function, and significance Hum Immunol 69 700 707 1:CAS:528:DC%2BD1cXhsVWls77I 18817832
103. P Tripathi S Agrawal 2007 The role of human leukocyte antigen E and G in HIV infection AIDS 21 1395 1404 17589185 (Pubitemid 46987999)
104. JM Lozano R Gonzalez JM Kindelan N Rouas-Freiss R Caballos J Dausset ED Carosella J Pena 2002 Monocytes and T-lymphocytes in HIV-1-positive patients express HLA-G molecule AIDS 16 347 351 1:CAS:528:DC%2BD38XitVKgs7w%3D 11834945 (Pubitemid 34165365)
105. A Cabello A Rivero MJ Garcia JM Lozano J Torre-Cisneros R Gonzalez G Duenas MD Galiani A Camacho M Santamaria R Solana C Montero JM Kindelan J Pena 2003 HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals Hum Immunol 64 1045 1049 1:CAS:528:DC%2BD3sXos1Kgu7o%3D 14602234 (Pubitemid 37413713)
106. A Rivero JM Lozano R Gonzalez G Garcia-Jurado A Camacho J Torres-Cisneros J Pena 2007 Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients Hum Immunol 68 303 306 1:CAS:528:DC%2BD2sXjslShsrc%3D 17400067 (Pubitemid 46497517)
107. S Adnan A Balamurugan A Trocha MS Bennett HL Ng A Ali C Brander OO Yang 2006 Nef interference with HIV-1-specific CTL antiviral activity is epitope specific Blood 108 3414 3419 1:CAS:528:DC%2BD28Xht1ahsL%2FK 16882705
108. N Pizzato M Derrien F Lenfant 2004 The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation Hum Immunol 65 1389 1396 1:CAS:528:DC%2BD2cXhtVSksb3J 15556689 (Pubitemid 39535301)
109. C Matte J Lajoie J Lacaille LS Zijenah BJ Ward M Roger 2004 Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women AIDS 18 427 431 1:CAS:528:DC%2BD2cXjsFSksb8%3D 15090794 (Pubitemid 38365869)
110. J Lajoie J Hargrove LS Zijenah JH Humphrey BJ Ward M Roger 2006 Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1 J Infect Dis 193 298 301 1:CAS:528:DC%2BD28XhtVynsrw%3D 16362895 (Pubitemid 43113493)
111. CS Clements L Kjer-Nielsen L Kostenko HL Hoare MA Dunstone E Moses K Freed AG Brooks J Rossjohn J McCluskey 2005 Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface Proc Natl Acad Sci USA 102 3360 3365 1:CAS:528:DC%2BD2MXitl2lur8%3D 15718280 (Pubitemid 40328050)
112. FO Aikhionbare K Kumaresan F Shamsa VC Bond 2006 HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission AIDS Res Ther 3 28 17059603
113. C Soderberg-Naucler JY Nelson 1999 Human cytomegalovirus latency and reactivation-a delicate balance between the virus and its host's immune system Intervirology 42 314 321 1:CAS:528:DC%2BD3cXisVKis7o%3D 10702712 (Pubitemid 30122065)
114. C Powers V DeFilippis D Malouli K Fruh 2008 Cytomegalovirus immune evasion Curr Top Microbiol Immunol 325 333 359 1:CAS:528:DC%2BD1cXhtF2mt7nP 18637515
115. WH Yan A Lin BG Chen SY Chen 2009 Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection J Infect Dis 200 820 826 1:CAS:528:DC%2BD1MXhtFChsLzP 19619059
116. S Fisher O Genbacev E Maidji L Pereira 2000 Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis J Virol 74 6808 6820 1:CAS:528: DC%2BD3cXkvFCmt78%3D 10888620 (Pubitemid 30470664)
117. Y Jun E Kim M Jin HC Sung H Han DE Geraghty K Ahn 2000 Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules J Immunol 164 805 811 1:CAS:528:DC%2BD3cXlt1Cmug%3D%3D 10623826 (Pubitemid 30043704)
118. H Wiendl 2007 HLA-G in the nervous system Hum Immunol 68 286 293 1:CAS:528:DC%2BD2sXjslShsrk%3D 17400065 (Pubitemid 46497519)
119. M Lafon C Prehaud F Megret M Lafage G Mouillot M Roa P Moreau N Rouas-Freiss ED Carosella 2005 Modulation of HLA-G expression in human neural cells after neurotropic viral infections J Virol 79 15226 15237 1:CAS:528:DC%2BD28XhslOiug%3D%3D 16306594 (Pubitemid 43032305)
120. EA Cordero TD Veit MA da Silva SM Jacques LM Silla JA Chies 2009 HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients Tissue Antigens 74 308 313 1:CAS:528:DC%2BD1MXhtlWks7vL 19775370
121. F LeBouder K Khoufache C Menier Y Mandouri M Keffous N Lejal I Krawice-Radanne ED Carosella N Rouas-Freiss B Riteau 2009 Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection Hum Immunol 70 1016 1019 1:CAS:528:DC%2BD1MXhsVajurjK 19664669
122. N Pizzato B Garmy-Susini P Le Bouteiller F Lenfant 2003 Down-regulation of HLA-G1 cell surface expression in human cytomegalovirus infected cells Am J Reprod Immunol 50 328 333 14672336 (Pubitemid 37203576)
123. MT Barel N Pizzato D van Leeuwen PL Bouteiller EJ Wiertz F Lenfant 2003 Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation Eur J Immunol 33 1707 1716 1:CAS:528: DC%2BD3sXkvF2rur4%3D 12778489 (Pubitemid 36790432)
124. F Megret C Prehaud M Lafage P Moreau N Rouas-Freiss ED Carosella M Lafon 2007 Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections Hum Immunol 68 294 302 1:CAS:528:DC%2BD2sXjslShsrY%3D 17400066 (Pubitemid 46497524)
125. + regulatory T cells are expanded in HIV-1-infected patients Viral Immunol 22 463 465 1:CAS:528:DC%2BD1MXhs1Wht7fJ 19951184
126. M Derrien N Pizzato G Dolcini E Menu G Chaouat F Lenfant F Barre-Sinoussi PL Bouteiller 2004 Human immunodeficiency virus-1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1 J Gen Virol 85 1945 1954 1:CAS:528:DC%2BD2cXlvFKhtLc%3D 15218179 (Pubitemid 39023273)
127. L Donaghy F Gros L Amiot C Mary A Maillard C Guiguen JP Gangneux 2007 Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis Clin Exp Immunol 147 236 240 1:CAS:528:DC%2BD2sXjtFChurk%3D 17223963 (Pubitemid 46096000)
128. J Lajoie J Fontaine C Tremblay JP Routy J Poudrier M Roger 2009 Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection AIDS 23 1437 1440 1:CAS:528:DC%2BD1MXnsl2gsLY%3D 19461504
129. FP Barry JM Murphy 2004 Mesenchymal stem cells: clinical applications and biological characterization Int J Biochem Cell Biol 36 568 584 1:CAS:528:DC%2BD2cXhvFSmurg%3D 15010324 (Pubitemid 38324589)
130. PA Lysy D Campard F Smets J Malaise M Mourad M Najimi EM Sokal 2008 Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells Cell Prolif 41 36 58 1:CAS:528: DC%2BD1cXivVSjtrg%3D 18211285
131. M Najimi DN Khuu PA Lysy N Jazouli J Abarca C Sempoux EM Sokal 2007 Adult derived human liver mesenchymal-like cells as a potential progenitors reservoir of hepatocytes? Cell Transplant 16 717 728 18019361 (Pubitemid 351448267)
132. D Campard PA Lysy M Najimi EM Sokal 2008 Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells Gastroenterology 134 833 848 1:CAS:528:DC%2BD1cXktlehtbw%3D 18243183 (Pubitemid 351312728)
133. A Bartholomew C Sturgeon M Siatskas K Ferrer K McIntosh S Patil W Hardy S Devine D Ucker R Deans A Moseley R Hoffman 2002 Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Exp Hematol 30 42 48 11823036 (Pubitemid 34059216)
134. K Le Blanc I Rasmusson B Sundberg C Gotherstrom M Hassan M Uzunel O Ringden 2004 Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 1439 1441 15121408 (Pubitemid 38586721)
135. S Beyth Z Borovsky D Mevorach M Liebergall Z Gazit H Aslan E Galun J Rachmilewitz 2005 Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T cell unresponsiveness Blood 105 2214 2219 1:CAS:528:DC%2BD2MXitVOnt7c%3D 15514012 (Pubitemid 40731815)
136. MJ Crop CC Baan SS Korevaar JN Ijzermans IP Alwayn W Weimar MJ Hoogduijn 2009 Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients Transplantation 87 896 906 19300194
137. K Le Blanc F Frassoni L Ball F Locatelli H Roelofs I Lewis E Lanino B Sundberg ME Bernardo M Remberger G Dini RM Egeler A Bacigalupo W Fibbe O Ringdén Developmental Committee of the European Group for Blood, Marrow Transplantation 2008 Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study Lancet 371 1579 1586 1:CAS:528:DC%2BD1cXlslWhsbk%3D 18468541 (Pubitemid 351626841)
138. T Hügle T Daikeler 2010 Stem cell transplantation for autoimmune diseases Haematologica 95 185 188 20139390
139. C Menier N Rouas-Freiss B Favier J LeMaoult P Moreau ED Carosella 2009 Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule Tissue Antigens 75 201 206 20047640
140. A Le Maux G Noël B Birebent J-M Grosset N Vu S De Guibert M Bernard G Semana L Amiot 2008 Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells Clin Exp Immunol 152 50 56 1:CAS:528:DC%2BD1cXkvFamt7c%3D 18241225 (Pubitemid 351347550)
141. A Nasef N Mathieu A Chapel J Frickm S Francois C Mazurier A Boutarfa S Bouchet NC Gorin D Thierry L Fouillard 2007 Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G Transplantation 84 231 237 1:CAS:528:DC%2BD2sXotlKitrY%3D 17667815 (Pubitemid 47205757)
142. E Ivanova-Todorova M Mourdjeva D Kyurkchiev I Bochev E Stoyanova R Dimitrov T Timeva M Yunakova D Bukarev A Shterev P Tivchev S Kyurkiev 2009 HLA-G expression is up-regulated by progesterone in mesenchymal stem cells Am J Reprod Immunol 62 25 33 1:CAS:528:DC%2BD1MXovV2hsbc%3D 19527229
143. O Blanco I Tirado R Munoz-Fernandez AC Abadia-Molina JM Garcia-Pacheco J Pena EG Olivares 2008 Human decidual stromal cells express HLA-G: effects of cytokines and decidualization Hum Reprod 23 144 152 1:CAS:528:DC%2BD2sXhsVWgsb3O 17951263 (Pubitemid 351767312)
144. A Nasef YZ Zhang C Mazurier S Bouchet M Bensidhoum S Francois C Gorin M Lopez D Thierry L Fouillard A Chapel 2009 Selected stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation Int J Lab Hem 31 9 19 1:STN:280:DC%2BD1M%2Fnt1Wgtw%3D%3D
145. D Campioni R Rizzo M Stignani L Melchiorri L Ferrari S Moretti A Russo GP Bagnara L Bonsi F Alviano G Lanzoni A Cuneo OR Baricordi F Lanza 2009 A decreased positivity for CD90 on human mesenchymal stromal cells is associated with a loss of immunosuppressive activity by MSCs Cytometry B Clin Cytom 76 225 230 18985728
146. ML Weiss C Anderson S Medicetty KB Seshareddy RJ Weiss I VanderWerff D Troyer KR McIntosh 2008 Immune properties of human umbilical cord warthon's jelly-derived cells Stem cells 26 2865 2874 1:CAS:528:DC%2BD1MXmsF2r 18703664
147. + mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers Histochem Cell Biol 131 267 282 1:CAS:528:DC%2BD1MXivFeitg%3D%3D 18836737
148. H Wiendl M Mitsdoerffer V Hofmeister J Wischhusen A Bornemann R Meyermann EH Weiss A Melms M Weller 2002 A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape J Immunol 168 4772 4780 1:CAS:528:DC%2BD38Xjt12jurg%3D 11971028 (Pubitemid 34441386)